Concepedia
Author
Aurore Perrot
Also Known As
A PERROT, A Perrot, A. Perrot, Aurore Perrot, Bruno Lioure, Perrot A, Perrot, A., Perrot, Aurore, Thorsten Braun
439
Publications
10.8K
Citations
43
H-Index
71
Concepts
All Affiliations
1
20
34
3.5K
2
17
22
2.4K
3
111
4
19
5
15
×
All Concepts
118
9.5K
41
Daratumumab plus Lenalidomide and Dexamethasone for Untreated Myeloma
Thierry Façon, Shaji Kumar, Torben Plesner, +27
New England Journal of Medicine
2019
947
Bortezomib, thalidomide, and dexamethasone with or without daratumumab before and after autologous stem-cell transplantation for newly diagnosed multiple myeloma (CASSIOPEIA): a randomised, open-label, phase 3 study
Philippe Moreau, Michel Attal, Cyrille Hulin, +55
The Lancet
Hematological MalignancyRadiation OncologyMedicineImmunologyHematology +7
922
Oral Selinexor–Dexamethasone for Triple-Class Refractory Multiple Myeloma
Ajai Chari, Dan T. Vogl, Maria Gavriatopoulou, +49
655
Isatuximab plus pomalidomide and low-dose dexamethasone versus pomalidomide and low-dose dexamethasone in patients with relapsed and refractory multiple myeloma (ICARIA-MM): a randomised, multicentre, open-label, phase 3 study
Michel Attal, Paul G. Richardson, S. Vincent Rajkumar, +123
Hematological MalignancyMedicineImmunologyHematologyPharmacotherapy +4
620
Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma
Pieter Sonneveld, Meletios Α. Dimopoulos, Mario Boccadoro, +40
2023
435
Triplet Therapy, Transplantation, and Maintenance until Progression in Myeloma
Paul G. Richardson, Susanna Jacobus, Edie Weller, +53
2022
428
Minimal residual disease negativity using deep sequencing is a major prognostic factor in multiple myeloma
Aurore Perrot, Valérie Lauwers‐Cancès, Jill Corre, +36
Blood
2018
408
Daratumumab, lenalidomide, and dexamethasone versus lenalidomide and dexamethasone alone in newly diagnosed multiple myeloma (MAIA): overall survival results from a randomised, open-label, phase 3 trial
Thierry Façon, Shaji Kumar, Torben Plesner, +26
The Lancet Oncology
Hematological MalignancyDexamethasone Versus LenalidomideMedicineHematologyMyeloid Neoplasia +6
2021
345
Prospective Evaluation of Magnetic Resonance Imaging and [<sup>18</sup>F]Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography at Diagnosis and Before Maintenance Therapy in Symptomatic Patients With Multiple Myeloma Included in the IFM/DFCI 2009 Trial: Results of the IMAJEM Study
Philippe Moreau, Michel Attal, Denis Caillot, +26
Journal of Clinical Oncology
Oncologic ImagingPet-mriProspective TrialOrthopaedic SurgeryOsteoporosis +17
2017
310
Final analysis of survival outcomes in the phase 3 FIRST trial of up-front treatment for multiple myeloma
Thierry Façon, Meletios Α. Dimopoulos, Angela Dispenzieri, +35
267
Page 1